1. Home
  2. AGMH vs PFSA Comparison

AGMH vs PFSA Comparison

Compare AGMH & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AGM Group Holdings Inc.

AGMH

AGM Group Holdings Inc.

HOLD

Current Price

$0.89

Market Cap

2.1M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

HOLD

Current Price

$0.50

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGMH
PFSA
Founded
2015
2009
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
AGMH
PFSA
Price
$0.89
$0.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
60.1K
558.2K
Earning Date
05-13-2026
04-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.06
$0.05
52 Week High
$18.10
$4.22

Technical Indicators

Market Signals
Indicator
AGMH
PFSA
Relative Strength Index (RSI) 42.48 42.58
Support Level $0.81 $0.44
Resistance Level $0.94 $0.66
Average True Range (ATR) 0.06 0.06
MACD 0.01 -0.00
Stochastic Oscillator 46.47 37.28

Price Performance

Historical Comparison
AGMH
PFSA

About AGMH AGM Group Holdings Inc.

AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: